The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for Modification To N/t Rheumatology Controls Sl 1 & 2.
| Device ID | K021381 |
| 510k Number | K021381 |
| Device Name: | MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2 |
| Classification | Multi-analyte Controls, All Kinds (assayed) |
| Applicant | DADE BEHRING, INC. 514 GBC DR. Newark, DE 19702 |
| Contact | Donna A Wolf |
| Correspondent | Donna A Wolf DADE BEHRING, INC. 514 GBC DR. Newark, DE 19702 |
| Product Code | JJY |
| CFR Regulation Number | 862.1660 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2002-05-01 |
| Decision Date | 2002-06-10 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00842768007279 | K021381 | 000 |
| 00842768007262 | K021381 | 000 |
| 00630414287423 | K021381 | 000 |
| 00630414287416 | K021381 | 000 |